Research and Funding

Funding Opportunities

Direct Phase II SBIR Grants to Support Biomedical Technology Development

Funding Number: PAR-14-088
Funding Type: PAR
Release Date: February 5, 2014
Expiration Date: January 8, 2017
Web Site:
The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization.